Peer Review reports
From: CircPRELID2 functions as a promoter of renal cell carcinoma through the miR-22-3p/ETV1 cascade
| Original Submission | ||
|---|---|---|
| 17 Nov 2023 | Submitted | Original manuscript |
| 6 Dec 2023 | Author responded | Author comments - Yi Zhi |
| 14 Dec 2023 | Author responded | Author comments - Yi Zhi |
| Resubmission - Version 2 | ||
| 6 Dec 2023 | Submitted | Manuscript version 2 |
| 5 Feb 2024 | Reviewed | Reviewer Report |
| 2 Mar 2024 | Reviewed | Reviewer Report - Haimin Zhang |
| 1 Apr 2024 | Author responded | Author comments - Yi Zhi |
| Resubmission - Version 3 | ||
| 1 Apr 2024 | Submitted | Manuscript version 3 |
| 2 Apr 2024 | Author responded | Author comments - Yi Zhi |
| Resubmission - Version 4 | ||
| 2 Apr 2024 | Submitted | Manuscript version 4 |
| 17 Apr 2024 | Reviewed | Reviewer Report |
| 22 Apr 2024 | Author responded | Author comments - Yi Zhi |
| Resubmission - Version 5 | ||
| 22 Apr 2024 | Submitted | Manuscript version 5 |
| Publishing | ||
| 23 Apr 2024 | Editorially accepted | |
| 10 May 2024 | Article published | 10.1186/s12894-024-01490-z |
You can find further information about peer review here.